At the news
? MIXEDIMPACT 5/10 CLUSTER filed May 6, 2026 at 20:00 ET
Atara Biotherapeutics saw a mixed insider cluster: 10% owner EcoR1 Capital bought $4.74M worth of shares, while director/10% owner Panacea Innovation sold $3.17M worth on the same day. The net $1.57M buying is modest relative to ATRA's $71M market cap (~2.2%), but the simultaneous insider buying and selling creates a conflicting signal that warrants caution.
- EcoR1 Capital purchased 507,407 shares at $9.35 for $4.74M on 2026-05-07
- Panacea Innovation sold 313,446 shares at $10.10 for $3.17M on 2026-05-07
- Net insider buying of ~$1.57M, representing ~2.2% of ATRA's $71M market cap
- Both parties are 10% owners; no C-suite insiders traded
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access